Grants and Contributions:
Title:
Development of INT-101 formulation for human dosing and prevention of diabetes
Agreement Number:
1040017
Agreement Value:
$379,022.00
Agreement Date:
Feb 10, 2026 - Mar 31, 2027
Description:
Development of INT-101 formulation for human dosing and prevention of diabetes
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Burnaby, British Columbia, CA V5G 4X4
Reference Number:
172-2025-2026-Q4-1040017
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
824601991
Recipient Type:
For-profit organization
Recipient's Operating Name:
INT
Recipient's Legal Name:
Integrated Nanotherapeutics Inc.
Federal Riding Name:
Burnaby South
Federal Riding Number:
59003
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
541710